NASDAQ · BHST
Basic Materials · Agricultural Inputs
$1.47
Up+$0.02 (+1.02%)
Updated Oct 7, 2026, 12:14 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BHST
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
BHST closed at $1.47 after 20 trading sessions, down 19.06% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.49 | $1.49 | $1.455 | $1.465 | 18.33K |
| Oct 2, 2026 | $1.60 | $1.60 | $1.451 | $1.47 | 19.59K |
| Oct 1, 2026 | $1.49 | $1.50 | $1.4501 | $1.49 | 29.12K |
| Sep 30, 2026 | $1.47 | $1.50 | $1.43 | $1.48 | 30.37K |
| Sep 29, 2026 | $1.47 | $1.52 | $1.47 | $1.47 | 69.6K |
| Sep 28, 2026 | $1.44 | $1.49 | $1.44 | $1.45 | 33.25K |
| Sep 25, 2026 | $1.43 | $1.47 | $1.42 | $1.46 | 12.02K |
| Sep 24, 2026 | $1.45 | $1.51 | $1.45 | $1.45 | 9.13K |
| Sep 23, 2026 | $1.50 | $1.77 | $1.45 | $1.46 | 41.31K |
| Sep 22, 2026 | $1.60 | $1.645 | $1.51 | $1.51 | 45.83K |
| Sep 21, 2026 | $1.61 | $1.6568 | $1.60 | $1.62 | 18.52K |
| Sep 18, 2026 | $1.62 | $1.65 | $1.60 | $1.63 | 13.47K |
| Sep 17, 2026 | $1.64 | $1.64 | $1.55 | $1.60 | 34.39K |
| Sep 16, 2026 | $1.73 | $1.7422 | $1.63 | $1.66 | 23.94K |
| Sep 15, 2026 | $1.80 | $1.865 | $1.62 | $1.775 | 64.5K |
| Sep 14, 2026 | $1.83 | $1.855 | $1.80 | $1.80 | 13.06K |
| Sep 11, 2026 | $1.87 | $1.90 | $1.80 | $1.85 | 28.35K |
| Sep 10, 2026 | $1.80 | $1.87 | $1.80 | $1.87 | 13.76K |
| Sep 9, 2026 | $1.85 | $1.93 | $1.80 | $1.80 | 36.81K |
| Sep 8, 2026 | $1.85 | $2.0493 | $1.80 | $1.81 | 27.25K |
The latest Smart Investors Daily articles mentioning BHST.
Company
Market Activity
Research & News
BHST research
Company profile and research snapshot.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 29, 2026
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said Tuesday its board has authorized a share repurchase program covering up to 5% of its outstanding common shares. The company, which develops and manufactures proprietary plant-based compositions for customers, partners and its own...
Yahoo · Sep 29, 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for customers, partners and its own portfolio, announced today that its Board of Directors has authorized a share repurchase program, structured in accordance with Canadian practices as a normal course issuer bid (the
Benzinga · Sep 29, 2026
BioHarvest Sciences Inc. (NASDAQ:BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical Synthesis company developing and manufacturing proprietary plant-based compositions for
Yahoo · Sep 15, 2026
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) has launched single-dose VINIA Daily Chews, a new delivery format for its proprietary red-grape cell composition designed to expand VINIA's addressable market. VINIA is a natural, non-GMO powder derived from red grape cells and is BioHarvest's...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BHST.
